(Q38044018)

27 August 2017

title

An update on antidepressant use and suicidality in pediatric depression (English)

1 reference

27 August 2017

0 references

0 references

0 references

5

Robert L Findling

1 reference

27 August 2017

4

Christine A Demeter

1 reference

27 August 2017

author name string

Clara Adegbite-Adeniyi

series ordinal

1

1 reference

27 August 2017

Brittany Gron

series ordinal

2

1 reference

27 August 2017

Brieana M Rowles

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

Expert Opinion on Pharmacotherapy

27 August 2017

published in

1 reference

27 August 2017

volume

13

1 reference

27 August 2017

issue

15

1 reference

27 August 2017

page(s)

2119-2130

1 reference

Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Validity of the Hamilton Rating Scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

The Montgomery-Asberg Depression Scale: reliability and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Persisting decline in depression treatment after FDA warnings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Rising prevalence of antidepressants among US youths

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Patterns of antidepressant use in Quebec children and adolescents: trends and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent P

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

National trends in the use of psychotropic medications by children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Effects of Food and Drug Administration warnings on antidepressant use in a national sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Depression treatment during outpatient visits by U.S. children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

The relationship between antidepressant prescription rates and rate of early adolescent suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Secular trends in antidepressant prescribing in the UK, 1975-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Impact of regulatory safety warnings on the use of antidepressants among children and adolescents in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Antidepressant use in children and adolescents in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Characterizing Declines in Pediatric Antidepressant Use After New Risk Disclosures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Pediatric prescribing practices and the FDA Black-box warning on antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Suicide in juveniles and adolescents in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Has adolescent suicidality decreased in the United States? Data from two national samples of adolescents interviewed in 1995 and 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Suicidal events in the Treatment for Adolescents With Depression Study (TADS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

Assessment of suicidal intention: The Scale for Suicide Ideation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.726613

10.1517/14656566.2012.726613

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference